Literature DB >> 26015484

Chlamydial variants differ in ability to ascend the genital tract in the guinea pig model of chlamydial genital infection.

Laxmi Yeruva1, Anne K Bowlin2, Nicole Spencer1, Anthony T Maurelli3, Roger G Rank4.   

Abstract

An important question in the study of chlamydial genital tract disease is why some women develop severe upper tract disease while others have mild or even "silent" infections with or without pathology. Animal studies suggest that the pathological outcome of an infection is dependent upon both the composition of the infecting chlamydial population and the genotype of the host, along with host physiological effects, such as the cyclical production of reproductive hormones and even the size of the infecting inoculum or the number of repeated infections. In this study, we compared two variants of Chlamydia caviae, contrasting in virulence, with respect to their abilities to ascend the guinea pig genital tract. We then determined the effect of combining the two variants on the course of infection and on the bacterial loads of the two variants in the genital tract. Although the variants individually had similar infection kinetics in the cervix, SP6, the virulent variant, could be isolated from the oviducts more often and in greater numbers than the attenuated variant, AZ2. SP6 also elicited higher levels of interleukin 8 (IL-8) in the lower genital tract and increased leukocyte infiltration in the cervix and uterus compared to AZ2. When the two variants were combined in a mixed infection, SP6 outcompeted AZ2 in the lower genital tract; however, AZ2 was able to ascend the genital tract as readily as SP6. These data suggest that the ability of SP6 to elicit an inflammatory response in the lower genital tract facilitates the spread of both variants to the oviducts.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26015484      PMCID: PMC4496626          DOI: 10.1128/IAI.00532-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.

Authors:  T Darville; C W Andrews; K K Laffoon; W Shymasani; L R Kishen; R G Rank
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 2.  Target cell limitation constrains chlamydial load in persistent infections: results from mathematical modelling applied to mouse genital tract infection data.

Authors:  Andrew P Craig; Roger G Rank; Anne K Bowlin; Handan Wand; David P Wilson
Journal:  Pathog Dis       Date:  2015-01-30       Impact factor: 3.166

3.  Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection.

Authors:  R G Rank; M M Sanders
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

4.  In vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract.

Authors:  Chaoqun Chen; Zhou Zhou; Turner Conrad; Zhangsheng Yang; Jin Dai; Zhongyu Li; Yimou Wu; Guangming Zhong
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

5.  Influence of the estrous cycle on the development of upper genital tract pathology as a result of chlamydial infection in the guinea pig model of pelvic inflammatory disease.

Authors:  R G Rank; M M Sanders; A T Kidd
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

6.  Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum.

Authors:  Lei Lei; Jianlin Chen; Shuping Hou; Yiling Ding; Zhangsheng Yang; Hao Zeng; Joel Baseman; Guangming Zhong
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

7.  The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle.

Authors:  R L Sweet; M Blankfort-Doyle; M O Robbie; J Schacter
Journal:  JAMA       Date:  1986-04-18       Impact factor: 56.272

8.  Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.

Authors:  K H Ramsey; L S Soderberg; R G Rank
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Genomic variant representation in a Chlamydia population is dynamic and adaptive with dependence on in vitro and in vivo passage.

Authors:  Deana K Jasper; Ira M Sigar; Justin H Schripsema; Carlyn K Sainvil; Christopher L Smith; Laxmi Yeruva; Roger G Rank; Ashlesh K Murthy; Jared R Widder; Kyle H Ramsey
Journal:  Pathog Dis       Date:  2015-01-28       Impact factor: 3.166

10.  Early microRNA expression profile as a prognostic biomarker for the development of pelvic inflammatory disease in a mouse model of chlamydial genital infection.

Authors:  Laxmi Yeruva; Garry S A Myers; Nicole Spencer; Heather Huot Creasy; Nancy E Adams; Anthony T Maurelli; Grant R McChesney; Mario A Cleves; Jacques Ravel; Anne Bowlin; Roger G Rank
Journal:  mBio       Date:  2014-06-24       Impact factor: 7.867

View more
  2 in total

1.  Endocervical miRNA Expression Profiles in Women Positive for Chlamydia trachomatis with Clinical Signs and/or Symptoms Are Distinct from Those in Women Positive for Chlamydia trachomatis without Signs and Symptoms.

Authors:  Teresa A Batteiger; Nicole Spencer; Charity L Washam; Stephanie Byrum; Michael Eledge; Byron E Batteiger; Roger G Rank; Laxmi Yeruva
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia.

Authors:  Marijana Stojanovic; Ivana Lukic; Emilija Marinkovic; Ana Kovacevic; Radmila Miljkovic; Joshua Tobias; Irma Schabussova; Mario Zlatović; Talin Barisani-Asenbauer; Ursula Wiedermann; Aleksandra Inic-Kanada
Journal:  Vaccines (Basel)       Date:  2020-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.